Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Research Report 2026(Status and Outlook)

December 2025 | 136 pages | ID: AE3E9D5A297CEN
Bosson Research

Abstracts

Alpha-1 antitrypsin deficiency (AATD) is an inherited condition characterized as a low or unpredictable level of alpha-1 protein, generated by liver. The disease most commonly affects lungs and liver and is often undiagnosed. Augmentation therapy is the most specific therapy for the treatment of AATD, and includes various preparations derived from pooled human plasma.

The global Alpha 1 Antitrypsin Deficiency Augmentation Therapy market size was estimated at USD 1250.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.80% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Alpha 1 Antitrypsin Deficiency Augmentation Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Alpha 1 Antitrypsin Deficiency Augmentation Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Alpha 1 Antitrypsin Deficiency Augmentation Therapy market.

Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company
Grifols
CSL
Baxter
Kamada
Takeda
Abeona

Market Segmentation (by Type)

Glassia
Aralast NP
Prolastin C
Others

Market Segmentation (by Application)

Hospitals
Specialty Clinics

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market

Overview of the regional outlook of the Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Alpha 1 Antitrypsin Deficiency Augmentation Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Alpha 1 Antitrypsin Deficiency Augmentation Therapy
1.2 Key Market Segments
  1.2.1 Alpha 1 Antitrypsin Deficiency Augmentation Therapy Segment by Type
  1.2.2 Alpha 1 Antitrypsin Deficiency Augmentation Therapy Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 ALPHA 1 ANTITRYPSIN DEFICIENCY AUGMENTATION THERAPY MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 ALPHA 1 ANTITRYPSIN DEFICIENCY AUGMENTATION THERAPY MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Product Life Cycle
3.3 Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales by Manufacturers (2020-2025)
3.4 Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Competitive Situation and Trends
  3.8.1 Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Alpha 1 Antitrypsin Deficiency Augmentation Therapy Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 ALPHA 1 ANTITRYPSIN DEFICIENCY AUGMENTATION THERAPY INDUSTRY CHAIN ANALYSIS

4.1 Alpha 1 Antitrypsin Deficiency Augmentation Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF ALPHA 1 ANTITRYPSIN DEFICIENCY AUGMENTATION THERAPY MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy ? April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market
5.7 ESG Ratings of Leading Companies

6 ALPHA 1 ANTITRYPSIN DEFICIENCY AUGMENTATION THERAPY MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales Market Share by Type (2020-2025)
6.3 Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2020-2025)
6.4 Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Price by Type (2020-2025)

7 ALPHA 1 ANTITRYPSIN DEFICIENCY AUGMENTATION THERAPY MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Sales by Application (2020-2025)
7.3 Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales Growth Rate by Application (2020-2025)

8 ALPHA 1 ANTITRYPSIN DEFICIENCY AUGMENTATION THERAPY MARKET SALES BY REGION

8.1 Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales by Region
  8.1.1 Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales by Region
  8.1.2 Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales Market Share by Region
8.2 Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region
  8.2.1 Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region
  8.2.2 Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region
8.3 North America
  8.3.1 North America Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales by Country
  8.3.2 North America Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales by Country
  8.4.2 Europe Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales by Region
  8.5.2 Asia Pacific Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales by Country
  8.6.2 South America Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales by Region
  8.7.2 Middle East and Africa Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 ALPHA 1 ANTITRYPSIN DEFICIENCY AUGMENTATION THERAPY MARKET PRODUCTION BY REGION

9.1 Global Production of Alpha 1 Antitrypsin Deficiency Augmentation Therapy by Region(2020-2025)
9.2 Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Alpha 1 Antitrypsin Deficiency Augmentation Therapy Production
  9.4.1 North America Alpha 1 Antitrypsin Deficiency Augmentation Therapy Production Growth Rate (2020-2025)
  9.4.2 North America Alpha 1 Antitrypsin Deficiency Augmentation Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Alpha 1 Antitrypsin Deficiency Augmentation Therapy Production
  9.5.1 Europe Alpha 1 Antitrypsin Deficiency Augmentation Therapy Production Growth Rate (2020-2025)
  9.5.2 Europe Alpha 1 Antitrypsin Deficiency Augmentation Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Alpha 1 Antitrypsin Deficiency Augmentation Therapy Production (2020-2025)
  9.6.1 Japan Alpha 1 Antitrypsin Deficiency Augmentation Therapy Production Growth Rate (2020-2025)
  9.6.2 Japan Alpha 1 Antitrypsin Deficiency Augmentation Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Alpha 1 Antitrypsin Deficiency Augmentation Therapy Production (2020-2025)
  9.7.1 China Alpha 1 Antitrypsin Deficiency Augmentation Therapy Production Growth Rate (2020-2025)
  9.7.2 China Alpha 1 Antitrypsin Deficiency Augmentation Therapy Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Grifols
  10.1.1 Grifols Basic Information
  10.1.2 Grifols Alpha 1 Antitrypsin Deficiency Augmentation Therapy Product Overview
  10.1.3 Grifols Alpha 1 Antitrypsin Deficiency Augmentation Therapy Product Market Performance
  10.1.4 Grifols Business Overview
  10.1.5 Grifols SWOT Analysis
  10.1.6 Grifols Recent Developments
10.2 CSL
  10.2.1 CSL Basic Information
  10.2.2 CSL Alpha 1 Antitrypsin Deficiency Augmentation Therapy Product Overview
  10.2.3 CSL Alpha 1 Antitrypsin Deficiency Augmentation Therapy Product Market Performance
  10.2.4 CSL Business Overview
  10.2.5 CSL SWOT Analysis
  10.2.6 CSL Recent Developments
10.3 Baxter
  10.3.1 Baxter Basic Information
  10.3.2 Baxter Alpha 1 Antitrypsin Deficiency Augmentation Therapy Product Overview
  10.3.3 Baxter Alpha 1 Antitrypsin Deficiency Augmentation Therapy Product Market Performance
  10.3.4 Baxter Business Overview
  10.3.5 Baxter SWOT Analysis
  10.3.6 Baxter Recent Developments
10.4 Kamada
  10.4.1 Kamada Basic Information
  10.4.2 Kamada Alpha 1 Antitrypsin Deficiency Augmentation Therapy Product Overview
  10.4.3 Kamada Alpha 1 Antitrypsin Deficiency Augmentation Therapy Product Market Performance
  10.4.4 Kamada Business Overview
  10.4.5 Kamada Recent Developments
10.5 Takeda
  10.5.1 Takeda Basic Information
  10.5.2 Takeda Alpha 1 Antitrypsin Deficiency Augmentation Therapy Product Overview
  10.5.3 Takeda Alpha 1 Antitrypsin Deficiency Augmentation Therapy Product Market Performance
  10.5.4 Takeda Business Overview
  10.5.5 Takeda Recent Developments
10.6 Abeona
  10.6.1 Abeona Basic Information
  10.6.2 Abeona Alpha 1 Antitrypsin Deficiency Augmentation Therapy Product Overview
  10.6.3 Abeona Alpha 1 Antitrypsin Deficiency Augmentation Therapy Product Market Performance
  10.6.4 Abeona Business Overview
  10.6.5 Abeona Recent Developments

11 ALPHA 1 ANTITRYPSIN DEFICIENCY AUGMENTATION THERAPY MARKET FORECAST BY REGION

11.1 Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size Forecast
11.2 Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size Forecast by Country
  11.2.3 Asia Pacific Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size Forecast by Region
  11.2.4 South America Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Alpha 1 Antitrypsin Deficiency Augmentation Therapy by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Alpha 1 Antitrypsin Deficiency Augmentation Therapy by Type (2026-2035)
  12.1.2 Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Alpha 1 Antitrypsin Deficiency Augmentation Therapy by Type (2026-2035)
12.2 Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Forecast by Application (2026-2035)
  12.2.1 Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales (K Units) Forecast by Application
  12.2.2 Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (M USD)
Table 4. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application
Table 5. Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size Comparison by Region (M USD)
Table 6. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha 1 Antitrypsin Deficiency Augmentation Therapy as of 2025)
Table 11. Global Market Alpha 1 Antitrypsin Deficiency Augmentation Therapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales by Type (K Units)
Table 27. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (M USD)
Table 28. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales (K Units) by Type (2020-2025)
Table 29. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales Market Share by Type (2020-2025)
Table 30. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size (M USD) by Type (2020-2025)
Table 31. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type (2020-2025)
Table 32. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Price (USD/Unit) by Type (2020-2025)
Table 33. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales (K Units) by Application
Table 34. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application
Table 35. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales by Application (2020-2025) & (K Units)
Table 36. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales Market Share by Application (2020-2025)
Table 37. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2020-2025) & (M USD)
Table 38. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application (2020-2025)
Table 39. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales Growth Rate by Application (2020-2025)
Table 40. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales by Region (2020-2025) & (K Units)
Table 41. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales Market Share by Region (2020-2025)
Table 42. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2020-2025) & (M USD)
Table 43. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2020-2025)
Table 44. North America Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales by Country (2020-2025) & (K Units)
Table 45. North America Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales by Country (2020-2025) & (K Units)
Table 47. Europe Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2020-2025) & (M USD)
Table 50. South America Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales by Country (2020-2025) & (K Units)
Table 51. South America Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2020-2025) & (M USD)
Table 54. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Production (K Units) by Region(2020-2025)
Table 55. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Region (2020-2025)
Table 57. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Alpha 1 Antitrypsin Deficiency Augmentation Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Alpha 1 Antitrypsin Deficiency Augmentation Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Alpha 1 Antitrypsin Deficiency Augmentation Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Alpha 1 Antitrypsin Deficiency Augmentation Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Grifols Basic Information
Table 63. Grifols Alpha 1 Antitrypsin Deficiency Augmentation Therapy Product Overview
Table 64. Grifols Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Grifols Business Overview
Table 66. Grifols SWOT Analysis
Table 67. Grifols Recent Developments
Table 68. CSL Basic Information
Table 69. CSL Alpha 1 Antitrypsin Deficiency Augmentation Therapy Product Overview
Table 70. CSL Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. CSL Business Overview
Table 72. CSL SWOT Analysis
Table 73. CSL Recent Developments
Table 74. Baxter Basic Information
Table 75. Baxter Alpha 1 Antitrypsin Deficiency Augmentation Therapy Product Overview
Table 76. Baxter Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Baxter Business Overview
Table 78. Baxter SWOT Analysis
Table 79. Baxter Recent Developments
Table 80. Kamada Basic Information
Table 81. Kamada Alpha 1 Antitrypsin Deficiency Augmentation Therapy Product Overview
Table 82. Kamada Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Kamada Business Overview
Table 84. Kamada Recent Developments
Table 85. Takeda Basic Information
Table 86. Takeda Alpha 1 Antitrypsin Deficiency Augmentation Therapy Product Overview
Table 87. Takeda Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Takeda Business Overview
Table 89. Takeda Recent Developments
Table 90. Abeona Basic Information
Table 91. Abeona Alpha 1 Antitrypsin Deficiency Augmentation Therapy Product Overview
Table 92. Abeona Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Abeona Business Overview
Table 94. Abeona Recent Developments
Table 95. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales Forecast by Region (2026-2035) & (K Units)
Table 96. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 97. North America Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 98. North America Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 99. Europe Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 100. Europe Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 101. Asia Pacific Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales Forecast by Region (2026-2035) & (K Units)
Table 102. Asia Pacific Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 103. South America Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 104. South America Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 105. Middle East and Africa Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales Forecast by Country (2026-2035) & (Units)
Table 106. Middle East and Africa Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 107. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales Forecast by Type (2026-2035) & (K Units)
Table 108. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size Forecast by Type (2026-2035) & (M USD)
Table 109. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Price Forecast by Type (2026-2035) & (USD/Unit)
Table 110. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales (K Units) Forecast by Application (2026-2035)
Table 111. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Alpha 1 Antitrypsin Deficiency Augmentation Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size (M USD), 2025-2035
Figure 5. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size (M USD) (2020-2035)
Figure 6. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Product Life Cycle
Figure 13. Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales Share by Manufacturers in 2025
Figure 14. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Revenue Share by Manufacturers in 2025
Figure 15. Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Alpha 1 Antitrypsin Deficiency Augmentation Therapy Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Alpha 1 Antitrypsin Deficiency Augmentation Therapy Revenue in 2025
Figure 18. Industry Chain Map of Alpha 1 Antitrypsin Deficiency Augmentation Therapy
Figure 19. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market PEST Analysis
Figure 20. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type
Figure 27. Sales Market Share of Alpha 1 Antitrypsin Deficiency Augmentation Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Alpha 1 Antitrypsin Deficiency Augmentation Therapy by Type in 2025
Figure 29. Market Share of Alpha 1 Antitrypsin Deficiency Augmentation Therapy by Type (2020-2025)
Figure 30. Market Share of Alpha 1 Antitrypsin Deficiency Augmentation Therapy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application
Figure 33. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales Market Share by Application in 2025
Figure 35. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application (2020-2025)
Figure 36. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application in 2025
Figure 37. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2020-2025)
Figure 40. North America Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales Market Share by Country in 2024
Figure 43. North America Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country in 2024
Figure 45. U.S. Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales Market Share by Country in 2024
Figure 53. Europe Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country in 2024
Figure 55. Germany Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region in 2024
Figure 68. China Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales and Growth Rate (K Units)
Figure 79. South America Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales Market Share by Country in 2024
Figure 80. South America Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size and Growth Rate (M USD)
Figure 81. South America Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country in 2024
Figure 82. Brazil Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region in 2024
Figure 92. Saudi Arabia Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Production Market Share by Region (2020-2025)
Figure 103. North America Alpha 1 Antitrypsin Deficiency Augmentation Therapy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Alpha 1 Antitrypsin Deficiency Augmentation Therapy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Alpha 1 Antitrypsin Deficiency Augmentation Therapy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Alpha 1 Antitrypsin Deficiency Augmentation Therapy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Share Forecast by Type (2026-2035)
Figure 111. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Sales Forecast by Application (2026-2035)
Figure 112. Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Share Forecast by Application (2026-2035)